Literature DB >> 33567531

The Edible Brown Seaweed Sargassum horneri (Turner) C. Agardh Ameliorates High-Fat Diet-Induced Obesity, Diabetes, and Hepatic Steatosis in Mice.

Shigeru Murakami1, Chihiro Hirazawa1, Takuma Ohya1, Rina Yoshikawa1, Toshiki Mizutani1, Ning Ma2, Mitsuru Moriyama3, Takashi Ito1, Chiaki Matsuzaki4.   

Abstract

Sargassum horneri (Turner) C. Agardh (S. horneri) is edible brown seaweed that grows along the coast of East Asia and has been traditionally used as a folk medicine and a local food. In this study, we evaluated the effects of S. horneri on the development of obesity and related metabolic disorders in C57BL/6J mice fed a high-fat diet. S. horneri was freeze-dried, fine-powdered, and mixed with a high-fat diet at a weight ratio of 2% or 6%. Feeding a high-fat diet to mice for 13 weeks induced obesity, diabetes, hepatic steatosis, and hypercholesterolemia. Supplementation of mice with S. horneri suppressed high-fat diet-induced body weight gain and the accumulation of fat in adipose tissue and liver, and the elevation of the serum glucose level. In addition, S. horneri improved insulin resistance. An analysis of the feces showed that S. horneri stimulated the fecal excretion of triglyceride, as well as increased the fecal polysaccharide content. Furthermore, extracts of S. horneri inhibited the activity of pancreatic lipase in vitro. These results showed that S. horneri can ameliorate diet-induced metabolic diseases, and the effect may be partly associated with the suppression of intestinal fat absorption.

Entities:  

Keywords:  Sargassum horneri (Turner) C. Agardh; diabetes; hepatic steatosis; high-fat diet; lipase inhibition; obesity; seaweed

Mesh:

Substances:

Year:  2021        PMID: 33567531      PMCID: PMC7915656          DOI: 10.3390/nu13020551

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  54 in total

Review 1.  Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis.

Authors:  Herbert Tilg; Alexander R Moschen
Journal:  Hepatology       Date:  2010-11       Impact factor: 17.425

Review 2.  Orlistat, a new lipase inhibitor for the management of obesity.

Authors:  A M Heck; J A Yanovski; K A Calis
Journal:  Pharmacotherapy       Date:  2000-03       Impact factor: 4.705

Review 3.  Review: efficacy of alginate supplementation in relation to appetite regulation and metabolic risk factors: evidence from animal and human studies.

Authors:  M Georg Jensen; C Pedersen; M Kristensen; G Frost; A Astrup
Journal:  Obes Rev       Date:  2012-11-12       Impact factor: 9.213

Review 4.  Adipokines in inflammation and metabolic disease.

Authors:  Noriyuki Ouchi; Jennifer L Parker; Jesse J Lugus; Kenneth Walsh
Journal:  Nat Rev Immunol       Date:  2011-01-21       Impact factor: 53.106

5.  Fucoidan prevents high-fat diet-induced obesity in animals by suppression of fat accumulation.

Authors:  Mi-Ja Kim; Joseph Jeon; Jin-Sil Lee
Journal:  Phytother Res       Date:  2013-04-12       Impact factor: 5.878

6.  Taurine improves obesity-induced inflammatory responses and modulates the unbalanced phenotype of adipose tissue macrophages.

Authors:  Shan Lin; Shizuka Hirai; Yuko Yamaguchi; Tsuyoshi Goto; Nobuyuki Takahashi; Fumito Tani; Chikako Mutoh; Takanobu Sakurai; Shigeru Murakami; Rina Yu; Teruo Kawada
Journal:  Mol Nutr Food Res       Date:  2013-08-12       Impact factor: 5.914

7.  First evidence for the anti-inflammatory activity of fucoxanthin in high-fat-diet-induced obesity in mice and the antioxidant functions in PC12 cells.

Authors:  Cong-ping Tan; Yun-hua Hou
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

Review 8.  Risks and benefits of consuming edible seaweeds.

Authors:  Paul Cherry; Cathal O'Hara; Pamela J Magee; Emeir M McSorley; Philip J Allsopp
Journal:  Nutr Rev       Date:  2019-05-01       Impact factor: 7.110

9.  Frequency of Seaweed Intake and Its Association with Cardiovascular Disease Mortality: The JACC Study.

Authors:  Rie Kishida; Kazumasa Yamagishi; Isao Muraki; Mizuki Sata; Akiko Tamakoshi; Hiroyasu Iso
Journal:  J Atheroscler Thromb       Date:  2020-03-05       Impact factor: 4.928

Review 10.  Seaweeds as Preventive Agents for Cardiovascular Diseases: From Nutrients to Functional Foods.

Authors:  Susana M Cardoso; Olívia R Pereira; Ana M L Seca; Diana C G A Pinto; Artur M S Silva
Journal:  Mar Drugs       Date:  2015-11-12       Impact factor: 5.118

View more
  7 in total

Review 1.  Nutraceutical potential of polyphenol-rich Sargassum species grown off the Korean coast: a review.

Authors:  Chan Seo; Seung Jin Jeong; Hyun Jung Yun; Hye Ju Lee; Joo Won Lee; Hyun Woo An; Nara Han; Won-Kyo Jung; Sang Gil Lee
Journal:  Food Sci Biotechnol       Date:  2022-03-19       Impact factor: 3.231

2.  Edible red seaweed Campylaephora hypnaeoides J. Agardh alleviates obesity and related metabolic disorders in mice by suppressing oxidative stress and inflammatory response.

Authors:  Shigeru Murakami; Chihiro Hirazawa; Rina Yoshikawa; Toshiki Mizutani; Takuma Ohya; Ning Ma; Takahiko Ikemori; Takashi Ito; Chiaki Matsuzaki
Journal:  Nutr Metab (Lond)       Date:  2022-01-08       Impact factor: 4.169

3.  Chlorophyll Inhibits the Digestion of Soybean Oil in Simulated Human Gastrointestinal System.

Authors:  Xiao Wang; Yuanyuan Li; Suxia Shen; Zhaotian Yang; Haifeng Zhang; Yan Zhang
Journal:  Nutrients       Date:  2022-04-22       Impact factor: 5.717

Review 4.  Potential Beneficial Effects of Sargassum spp. in Skin Aging.

Authors:  Min-Kyeong Lee; Heeyeon Ryu; Ji Yun Lee; Hyeon Hak Jeong; Jiwon Baek; Ji Yun Van; Myeong-Jin Kim; Won-Kyo Jung; Bonggi Lee
Journal:  Mar Drugs       Date:  2022-08-22       Impact factor: 6.085

5.  Effect of crude polysaccharide from seaweed, Dictyopteris divaricata (CDDP) on gut microbiota restoration and anti-diabetic activity in streptozotocin (STZ)-induced T1DM mice.

Authors:  Nimra Zafar Siddiqui; Ata Ur Rehman; Waleed Yousuf; Asif Iqbal Khan; Nabeel Ahmed Farooqui; Shizhu Zang; Yi Xin; Liang Wang
Journal:  Gut Pathog       Date:  2022-09-17       Impact factor: 5.324

Review 6.  Fucoxanthin and Colorectal Cancer Prevention.

Authors:  Masaru Terasaki; Atsuhito Kubota; Hiroyuki Kojima; Hayato Maeda; Kazuo Miyashita; Chikara Kawagoe; Michihiro Mutoh; Takuji Tanaka
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

Review 7.  Effect of Microalgae and Macroalgae Extracts on Non-Alcoholic Fatty Liver Disease.

Authors:  Maitane González-Arceo; Saioa Gómez-Zorita; Leixuri Aguirre; María P Portillo
Journal:  Nutrients       Date:  2021-06-11       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.